artemisinin has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Chen, X; Chen, Y; Hu, W; Hua, L; Liang, S; Liu, Z; Ou, Y; Sun, P; Wu, D; Wu, X; Yan, Y; Yang, Z; Zhou, Y | 1 |
| Chen, Z; Li, T; Zhu, X | 1 |
2 other study(ies) available for artemisinin and Colitis Gravis
| Article | Year |
|---|---|
Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis.
Topics: Antimalarials; Artemisinins; Colitis, Ulcerative; Humans; Inflammasomes; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species | 2022 |
[Oral administration of artemisinin nanospheres alleviates inflammation in mice with spontaneous ulcerative colitis].
Topics: Administration, Oral; Animals; Artemisinins; Colitis, Ulcerative; Disease Models, Animal; Inflammation; Mice; Nanospheres; RNA, Messenger | 2023 |